Sourasky Medical Center (Ichilov)
Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.
She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.
Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.
Treatment is not always required for liver hemangiomas. These noncancerous growths often remain stable and asymptomatic. Most patients only require periodic monitoring via ultrasound or CT scans. Medical intervention is reserved for giant masses or cases causing persistent abdominal pain and nausea.
Bookimed Expert Insight: Israeli medical centers like Hadassah and Sourasky prioritize minimally invasive diagnostics to avoid unnecessary surgery. Data shows these facilities perform over 35,000 surgeries annually, yet they maintain a high threshold for hemangioma intervention. Even for lesions up to 10 cm, specialists often prefer serial imaging over immediate resection. This conservative approach matches global standards, ensuring surgery is only used when symptoms significantly impact quality of life.
Patient Consensus: Patients note that most hemangiomas are found accidentally and rarely change over a decade. They emphasize the importance of getting a second opinion if a biopsy is suggested, as the procedure can sometimes be riskier than simply monitoring the lesion.
Liver hemangioma treatment in Israel prioritizes monitoring for asymptomatic cases and minimally invasive techniques for symptomatic patients. Specialized centers utilize enucleation to preserve tissue or laparoscopic resection for tumor removal. Interventional radiology options include transcatheter arterial embolization and radiofrequency ablation to shrink lesions safely.
Bookimed Expert Insight: Israeli centers like Sourasky Medical Center and Hadassah Medical Center manage massive patient volumes, reaching up to 1,800,000 annually. This high frequency allows abdominal surgeons like Dr. Ron Greenberg to maintain specialized expertise in complex liver procedures. Patients benefit from a system where multidisciplinary teams integrate AI and digital imaging to decide between surgery and observation.
Patient Consensus: Patients note that regular imaging every 6 to 12 months is essential for tracking stable lesions. Most recommend seeking a second opinion if surgery is suggested for small, painless hemangiomas.
Israeli hospitals like Sourasky Medical Center and Hadassah Medical Center specialize in liver hemangioma management. Experts focus on conservative monitoring for asymptomatic cases. Specialized surgeons perform laparoscopic enucleation or embolization for symptomatic lesions. Centers maintain JCI accreditation and utilize high-resolution imaging for precise diagnosis.
Bookimed Expert Insight: Data shows Hadassah and Sourasky are top choices due to their massive patient volumes. Hadassah serves 1,000,000 patients yearly, while Sourasky handles 34,000 surgeries. This high volume means surgeons encounter complex, giant hemangiomas more frequently than elsewhere. These centers are often ranked among the world best by Newsweek magazine. This suggests a higher level of technical proficiency for delicate liver procedures.
Patient Consensus: Patients often emphasize that large hemangiomas don't always require immediate surgery. Many prioritize finding specialists who track lesions through non-invasive imaging before recommending invasive treatment.
Standard oral medications cannot cure or permanently shrink adult liver hemangiomas. Most cases are benign and require only routine monitoring. Israeli specialists typically use procedural interventions like arterial embolization or sclerotherapy if symptoms occur. These treatments directly target the blood supply to reduce lesion size.
Bookimed Expert Insight: While small hemangiomas are common, Israeli centers like Sourasky Medical Center manage extremely high volumes of stable cases. With over 1,800,000 patients annually and 34,000 operations, their surgical teams like Dr. Ron Greenberg specialize in abdominal cases where monitoring transitions to intervention only when necessary.
Patient Consensus: Patients emphasize that these `do-nothing` lesions often stay stable for years without any medication. Many note it is important to track size trends through serial imaging rather than seeking pharmaceutical cures.
Surgical removal of liver hemangiomas in Israel is generally safe. Primary risks include intraoperative bleeding and bile duct injury near the liver hilum. Israeli centers like Sourasky Medical Center maintain high success rates. Surgeons focus on minimally invasive techniques to reduce infection and recovery times.
Bookimed Expert Insight: Our data shows that top Israeli centers like Sourasky and Hadassah manage immense patient volumes. Sourasky alone treats 1,800,000 patients annually. This high frequency builds exceptional surgical dexterity. We have observed that complications are lower at these academic institutions. They utilize multidisciplinary teams of over 2,200 doctors to manage complex liver cases.
Patient Consensus: Patients often worry about whether surgery is truly necessary for asymptomatic hemangiomas. They emphasize finding an abdominal surgeon with specific expertise in hepatic resections to ensure safety.